There is good evidence to suggest that HPV-positive OPSCC contain abundant CD8+ T-cells that can recognise tumour cell-expressed HPV antigens, enabling activation of adaptive immune responses to eliminate cancer cells and impart improved outcome [5–7]. Here, CD8A is linked to neoplasm.